Cargando…

Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression

BACKGROUND: Circular RNAs (circRNAs) dysregulation has been revealed to function in the pathological processes of cancers. Herein, the role and mechanisms of hsa_circ_0002082 in breast cancer (BC) progression were elucidated. METHODS: In vivo and in vitro functional experiments were conducted, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu, Liu, Yun, Luo, Jinyong, Zhao, Wen, Hu, Chunhui, Chen, Gongquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701879/
https://www.ncbi.nlm.nih.gov/pubmed/36161346
http://dx.doi.org/10.1002/jcla.24697
_version_ 1784839639083778048
author Liu, Yu
Liu, Yun
Luo, Jinyong
Zhao, Wen
Hu, Chunhui
Chen, Gongquan
author_facet Liu, Yu
Liu, Yun
Luo, Jinyong
Zhao, Wen
Hu, Chunhui
Chen, Gongquan
author_sort Liu, Yu
collection PubMed
description BACKGROUND: Circular RNAs (circRNAs) dysregulation has been revealed to function in the pathological processes of cancers. Herein, the role and mechanisms of hsa_circ_0002082 in breast cancer (BC) progression were elucidated. METHODS: In vivo and in vitro functional experiments were conducted, and the interaction between miR‐508‐3p and hsa_circ_0002082 or Centromere Protein F (CENPF) was elucidated. RESULTS: Hsa_circ_0002082 expression was higher in BC tissues and cell lines. Functionally, knockdown of hsa_circ_0002082 induced apoptosis and suppressed proliferation and metastasis in BC cells in vitro. Mechanistically, hsa_circ_0002082 targeted miR‐508‐3p, which was confirmed to be decreased in BC. MiR‐508‐3p overexpression suppressed BC cell malignant phenotypes, moreover, inhibition of miR‐508‐3p attenuated the anticancer action of hsa_circ_0002082 silencing on BC cells. Besides that, miR‐508‐3p targeted CENPF, CENPF was highly expressed in BC, CENPF up‐regulation reversed the suppressive impacts of miR‐508‐3p on BC cell growth and metastasis. Besides, hsa_circ_0002082 silencing impeded BC growth in nude mice. CONCLUSION: Knockdown of hsa_circ_0002082 suppresses breast cancer growth and metastasis by miR‐508‐3p/CENPF axis, suggesting that hsa_circ_0002082 may be a promising target for breast cancer treatment.
format Online
Article
Text
id pubmed-9701879
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97018792022-11-28 Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression Liu, Yu Liu, Yun Luo, Jinyong Zhao, Wen Hu, Chunhui Chen, Gongquan J Clin Lab Anal Research Articles BACKGROUND: Circular RNAs (circRNAs) dysregulation has been revealed to function in the pathological processes of cancers. Herein, the role and mechanisms of hsa_circ_0002082 in breast cancer (BC) progression were elucidated. METHODS: In vivo and in vitro functional experiments were conducted, and the interaction between miR‐508‐3p and hsa_circ_0002082 or Centromere Protein F (CENPF) was elucidated. RESULTS: Hsa_circ_0002082 expression was higher in BC tissues and cell lines. Functionally, knockdown of hsa_circ_0002082 induced apoptosis and suppressed proliferation and metastasis in BC cells in vitro. Mechanistically, hsa_circ_0002082 targeted miR‐508‐3p, which was confirmed to be decreased in BC. MiR‐508‐3p overexpression suppressed BC cell malignant phenotypes, moreover, inhibition of miR‐508‐3p attenuated the anticancer action of hsa_circ_0002082 silencing on BC cells. Besides that, miR‐508‐3p targeted CENPF, CENPF was highly expressed in BC, CENPF up‐regulation reversed the suppressive impacts of miR‐508‐3p on BC cell growth and metastasis. Besides, hsa_circ_0002082 silencing impeded BC growth in nude mice. CONCLUSION: Knockdown of hsa_circ_0002082 suppresses breast cancer growth and metastasis by miR‐508‐3p/CENPF axis, suggesting that hsa_circ_0002082 may be a promising target for breast cancer treatment. John Wiley and Sons Inc. 2022-09-26 /pmc/articles/PMC9701879/ /pubmed/36161346 http://dx.doi.org/10.1002/jcla.24697 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Liu, Yu
Liu, Yun
Luo, Jinyong
Zhao, Wen
Hu, Chunhui
Chen, Gongquan
Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression
title Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression
title_full Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression
title_fullStr Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression
title_full_unstemmed Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression
title_short Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progression
title_sort hsa_circ_0002082 up‐regulates centromere protein f via abolishing mir‐508‐3p to promote breast cancer progression
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701879/
https://www.ncbi.nlm.nih.gov/pubmed/36161346
http://dx.doi.org/10.1002/jcla.24697
work_keys_str_mv AT liuyu hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression
AT liuyun hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression
AT luojinyong hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression
AT zhaowen hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression
AT huchunhui hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression
AT chengongquan hsacirc0002082upregulatescentromereproteinfviaabolishingmir5083ptopromotebreastcancerprogression